Mesenchymal stem cells in the treatment of chronic lung disease.

  title={Mesenchymal stem cells in the treatment of chronic lung disease.},
  author={Sophie Wecht and Mauricio Enrique Mena Rojas},
  volume={21 8},
Mesenchymal stem cells (MSCs) are a populace of non-haematopoietic multipotent stromal cells, which have the ability to differentiate into tissue derived from a single germ layer. MSCs have been isolated from various sites, including adipose tissue, skeletal muscle, synovium, spleen, thymus, lung and amniotic fluid, but are most often isolated from bone marrow. MSCs have several valuable functions that make them a promising therapeutic option in the field of regenerative medicine, including the… CONTINUE READING
Highly Cited
This paper has 25 citations. REVIEW CITATIONS
Recent Discussions
This paper has been referenced on Twitter 9 times over the past 90 days. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 13 extracted citations


Publications referenced by this paper.
Showing 1-10 of 71 references

Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways

  • W Gu, L Song, Li X-M, D Wang, Guo X-J, Xu W-G
  • Sci. Rep. 2015;
  • 2015

Risk factors and early origins of chronic obstructive pulmonary disease

  • D Postma, A Bush, M. Berge
  • Lancet
  • 2015

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

  • L Richeldi, RM duBois, +8 authors INPULSIS Trial Investigators
  • N. Engl. J. Med
  • 2014

Similar Papers

Loading similar papers…